• Tempus AI, Inc. is trading at $47.50 (down 4.2%) as investors appear to be locking in profits following a sharp rebound earlier in the week.
  • This comes despite recent positive company-specific news, including the multi-center validation of its AI-enabled ECG model for predicting atrial fibrillation risk, announced on June 11, 2026.
  • The decline appears to be a technical pullback from recent momentum, rather than a response to a new negative catalyst.